More Reuters
View Older Stories View Newer Stories-
India's MobiKwik gets central bank nod for non-banking financial company licence
-
DeepSeek's new AI model does not wow markets in fast-changing industry
-
LNG tanker orders gain pace despite mixed outlook from Iran war
-
Modi's BJP gains ground in India’s upper house after AAP lawmakers defect
-
King Charles arrives in US for state visit amid differences over Iran war
-
Sawe's marathon record boosts Adidas in 'supershoe' race with Nike
-
European shares edge lower as US-Iran talks stall; central bank meetings in focus
-
UK police make another arrest in relation to attacks on Jewish-linked premises
-
Rents in Germany climb in first quarter, property prices stay flat, IW says
-
Energy prices drag German consumer sentiment to three-year low, survey finds
-
Lightning strikes kill 14 as Bangladesh lashed by seasonal storms
-
China's DeepSeek slashes prices for new AI model
-
China's DeepSeek slashes prices for new AI model
-
China's DeepSeek slashes prices for new AI model
-
China's DeepSeek slashes prices for new AI model
-
China's DeepSeek slashes prices for new AI model
-
China's DeepSeek slashes prices for new AI model
-
China's DeepSeek slashes prices for new AI model
-
China's DeepSeek slashes prices for new AI model
-
China's DeepSeek slashes prices for new AI model
-
China's DeepSeek slashes prices for new AI model
-
China's DeepSeek slashes prices for new AI model
-
China's DeepSeek slashes prices for new AI model
-
China's DeepSeek slashes prices for new AI model
-
China's DeepSeek slashes prices for new AI model
-
Sun Pharma to buy US drugmaker Organon for $11.75 billion in India's largest pharma deal
-
Sun Pharma to buy US drugmaker Organon for $11.75 billion in India's largest pharma deal
-
Sun Pharma to buy US drugmaker Organon for $11.75 billion in India's largest pharma deal
-
Sun Pharma to buy US drugmaker Organon for $11.75 billion in India's largest pharma deal
-
Sun Pharma to buy US drugmaker Organon for $11.75 billion in India's largest pharma deal
-
Sun Pharma to buy US drugmaker Organon for $11.75 billion in India's largest pharma deal
-
Sun Pharma to buy US drugmaker Organon for $11.75 billion in India's largest pharma deal
-
Sun Pharma to buy US drugmaker Organon for $11.75 billion in India's largest pharma deal
-
Sun Pharma to buy US drugmaker Organon for $11.75 billion in India's largest pharma deal
-
Sun Pharma to buy US drugmaker Organon for $11.75 billion in India's largest pharma deal
-
Sun Pharma to buy US drugmaker Organon for $11.75 billion in India's largest pharma deal
-
Sun Pharma to buy US drugmaker Organon for $11.75 billion in India's largest pharma deal
-
Sun Pharma to buy US drugmaker Organon for $11.75 billion in India's largest pharma deal
-
Russian drone attack on Odesa wounds 14, officials say
-
Eutelsat CEO says US demand holds despite SpaceX push to curb European rivals
-
Bank of England to keep rates on hold while it gauges impact of Iran war
-
Iran war disrupts the circuit board supply chain, raises costs for tech firms
-
US reviews latest Iranian proposal to end war stalemate
-
Toyota sales fall for second month in March on Middle East slump, RAV4 model change
-
Morning Bid: Hormuz and hyperscalers
-
US presses Taiwan parliament to pass 'comprehensive' defence budget
-
SK Hynix shares rally 7% to a record high, beating Samsung's 2.5% gain
-
Turkey's Erdogan offers support to Trump in call after White House dinner shooting
-
Tsunami survivor battles wildfire to protect hometown in Japan's northeast
-
Kia CEO signals price cuts in Europe to fend off Chinese competition
